Lukas Weiss

Publikationen pro Jahr

Filter

2020

Correction: The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab.
Magnes, T. (Erstautor/-in), Melchardt, T. (Erstautor/-in), Hufnagl, C. (Co-Autor/-in), Weiss, L. (Co-Autor/-in), Mittermair, C., Neureiter, D. (Co-Autor/-in), Klieser, E. (Co-Autor/-in), Rinnerthaler, G. (Co-Autor/-in), Roesch, S. (Co-Autor/-in), Gaggl, A. (Co-Autor/-in), Greil, R. (Co-Autor/-in) & Egle, A. (Letztautor/-in), 2020, in: PHARMACOGENOMICS J. 20, 2, S. 350
Publikation: Beitrag in Fachzeitschrift › Korrektur › Begutachtung
2018

Correction to: Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.
Egle, A. (Erstautor/-in), Steurer, M., Melchardt, T. (Co-Autor/-in), Weiss, L. (Co-Autor/-in), Gassner, F. J. (Co-Autor/-in), Zaborsky, N. (Co-Autor/-in), Geisberger, R. (Co-Autor/-in), Catakovic, K., Hartmann, T. (Co-Autor/-in), Pleyer, L. (Co-Autor/-in), Voskova, D., Thaler, J., Lang, A., Girschikofsky, M., Petzer, A. & Greil, R. (Letztautor/-in), 2018, in: ANNALS OF HEMATOLOGY . 97, 9, S. 1745
Publikation: Beitrag in Fachzeitschrift › Korrektur › Begutachtung

1 Quellenangabe (Web of Science)

Publikationen